- IBM Corp., the health insurer WellPoint Inc. and MSKCC announced two Watson-based applications – one to help diagnose and treat lung cancer and one to help manage health insurance decisions and claims.
- A press release announced that researchers at MSKCC have treated the first patient with a new experimental vaccinia virus-based cancer therapy designed for patients with malignant pleural mesothelioma or non-small cell lung cancer.
- Peter Bach of MSKCC is quoted in a Nature News article about the impact of the economic downturn on US academic medical campuses like the University of California, San Francisco (UCSF).